This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Hub and Specialty Pharmacy Models East

Hundreds of Your Peers Unite In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 19-21, 2024
Pre-Conference Workshops on March 18, 2024Philadelphia Marriott Downtown | Philadelphia, PA
March 19-21, 2024
Pre-Conference Workshops on March 18, 2024,
Philadelphia Marriott Downtown | Philadelphia, PA

Groundbreaking Strategies to Optimize Hub Models and Propel Patient Access and Adherence

Key stakeholders unite for unrivaled collaboration to optimize access and explore proven strategies and cutting-edge approaches to drive an all-encompassing, state-of-the-art hub.

Hub and Specialty Pharmacy Models East: Part of Access USA

Hundreds from the access community came together as three industry-leading events united under one roof for compelling discussions, industry benchmarking and extended networking. What happened? Click play to see event highlights and why you can't miss this pivotal access forum!

Revolutionize Your Patient Services Suite to Drive Medication Access and Adherence

Next-Level Content Providing Strategies and Solutions to Ensure End-to-End Access and Hub Optimization

  • Conference Breakouts for a Customizable Event Experience
  • Three Pre-Conference Workshops on Advocacy/Engagement, Alternative Funding Programs and Product Launch and Commercialization
  • Inspiring and Informative Keynote Presentations, Panels, Q&As and More with Regulators and Leaders from Across Industry
  • Fresh ideas and trailblazing solutions from leading service providers 

The Only Event Uniting Manufacturers, Specialty Pharmacies, Hub Providers and More

Collaborate with key stakeholders, expand your network and create powerful partnerships at Hub and Specialty Pharmacy Models East. Benefit from expert-led discussions, including representatives of:

  • EMD Serono
  • Genentech
  • Sanofi
  • Lexicon Pharmaceuticals
  • PhRMA
  • Elevar Therapeutics
  • BioCryst Pharmaceuticals,
  • DOJ
  • AbbVie
  • And more! 

Crucial Insights on Industry Trends to Drive Innovative Hub Programs and Patient-Centric Services

Industry trailblazers, like-minded peers and top solution providers will engage in compelling discussions on the most pressing topics facing industry right now, including:

  • How to optimize your hub model to streamline patient communication and access
  • Leveraging innovative services to tailor your operational strategy and increase patient engagement
  • Navigating regulatory reform and the ever-evolving policy and payer landscape

Never Miss a Moment with Streamly

NEW! As a Hub and Specialty Pharmacy Models East delegate, you have complimentary access to our Streamly digital platform to view sessions on-demand for up to 12 months post-event. Catch up on anything you missed or re-watch your favorite sessions – It has never been easier to review conference content!

Please note in a minority of cases, speakers may request their sessions are excluded from this on-demand access. In addition, closed-door conversations are not available on-demand.

Connect and Network with Key Decision-Makers at Hub and Specialty Pharmacy Models East

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

For more information about custom opportunities to reach a qualified audience, please contact Karen Hanover: karenh@informaconnectls.com

Past Attendee

The conference was terrific because we had a diverse group of people who all shared difference perspectives on key topics such as RTBC and specialty medicine e-prescribing, leading to a greater understanding of what’s happening in the healthcare market and what we can do to prepare for changes.